American International Group, Inc. Pfizer Inc Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $105,346 - $120,971	-4,069 Reduced 0.28%	1,430,132 $39.7 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $1.38 Million - $1.79 Million	-52,697 Reduced 3.54%	1,434,201 $41.3 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $789,285 - $922,595	-24,596 Reduced 1.63%	1,486,898 $49.3 Million
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $1.16 Million - $1.34 Million	32,157 Added 2.17%	1,511,494 $55.4 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $290,973 - $378,805	7,387 Added 0.5%	1,479,337 $60.4 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $1.27 Million - $1.66 Million	-30,511 Reduced 2.03%	1,471,950 $75.5 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.62 Million - $1.98 Million	-36,976 Reduced 2.4%	1,502,461 $65.7 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $2.03 Million - $2.4 Million	-43,581 Reduced 2.75%	1,539,437 $80.7 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $2.06 Million - $2.56 Million	-45,095 Reduced 2.77%	1,583,018 $82 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $672,317 - $996,598	16,271 Added 1.01%	1,628,113 $96.1 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $3.84 Million - $4.93 Million	-97,872 Reduced 5.72%	1,611,842 $69.3 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $830,131 - $940,399	-23,117 Reduced 1.33%	1,709,714 $67 Million
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $1.75 Million - $1.97 Million	-52,171 Reduced 2.92%	1,732,831 $62.8 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $169 Million - $214 Million	-5,038,027 Reduced 73.84%	1,785,002 $65.7 Million
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $25.7 Million - $30.2 Million	-810,008 Reduced 10.61%	6,823,029 $250 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $22 Million - $26.6 Million	-729,200 Reduced 8.72%	7,633,037 $250 Million
Q1 2020 May 04, 2020	SELL	$27.03 - $38.62 $54.7 Million - $78.1 Million	-2,022,060 Reduced 19.47%	8,362,237 $273 Million
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $10.7 Million - $12.2 Million	326,103 Added 3.24%	10,384,297 $407 Million
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $12.1 Million - $15.7 Million	-372,014 Reduced 3.57%	10,058,194 $361 Million
Q2 2019 Aug 13, 2019	SELL	$36.98 - $41.52 $20.6 Million - $23.1 Million	-555,913 Reduced 5.06%	10,430,208 $452 Million
Q1 2019 May 06, 2019	SELL	$37.5 - $41.2 $20.3 Million - $22.4 Million	-542,626 Reduced 4.71%	10,986,121 $467 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $125 Million - $142 Million	-3,245,745 Reduced 21.97%	11,528,747 $503 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $15.3 Million - $18.6 Million	-445,228 Reduced 2.93%	14,774,492 $651 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $19.7 Million - $21 Million	-595,915 Reduced 3.77%	15,219,720 $552 Million
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $5.36 Million - $6.22 Million	-167,945 Reduced 1.05%	15,815,635 $561 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $20.4 Million - $21.6 Million	612,095 Added 3.98%	15,983,580 $579 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $477 Million - $525 Million	15,371,485	15,371,485 $549 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.7 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.73 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.46 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account